Skip to main content

Woodworth Emily's Form 4 filing

Boston Scientific Corp (BSX) · filed Mar 5, 2025

Accession no.
0001225208-25-002992
Filed
Mar 5, 2025
Trade date
Mar 3-4, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $800.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Woodworth EmilyCIK 0002013518Officer (SVP, Global Controller and CAO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockMOption exerciseAcquired+5,949$37.50+$223,087.58,063Direct
Mar 3, 2025Common StockSSaleDisposed−7,149$104.97−$750,430.53914Direct
Mar 4, 2025Common StockSSaleDisposed−482$104.63−$50,431.66432Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2025Common StockMOption exerciseDisposed−5,949$0.00$02,383Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)